Sotera Health CoSHC财报
Nasdaq · 医疗保健 · 服务-其他健康及相关服务（未另分类）
Sotera Health Co是全球领先的医疗安全解决方案提供商，面向医疗器械厂商、制药企业、食品及消费品公司提供灭菌服务、实验室分析检测与合规咨询支持，帮助客户满足监管要求，保障上市产品的使用安全。
主要股东
| 股东 | 持股比例 | 股数 | 变动 | 截至 |
|---|---|---|---|---|
| GTCR INVESTMENT XI LLC | 43.40% | 123.0M | — | 2024-11-14 |
| OF ABOVE PERSON | 43.30% | 123.0M | — | 2024-11-14 |
| NOS. OF ABOVE PERSONS | 7.10% | 20.0M | — | 2024-09-13 |
| The Vanguard Group | 5.20% | 14.8M | 无变化 | 2024-11-12 |
内部人交易
Net 90d: −$610.80M · buys $0 / sells $610.80M时间范围:
类型:
身份:
| 内部人 | 身份 | 类型 | ||||
|---|---|---|---|---|---|---|
| 2026-03-06 | GTCR INVESTMENT XI LLC | Director | Sell (open market) | 10.00M | $15.27 | $152.70M |
| 2026-03-06 | WARBURG PINCUS & CO. | Director | Sell (open market) | 15.00M | $15.27 | $229.05M |
| 2026-03-06 | WARBURG PINCUS & CO. | Director | Sell (open market) | 15.00M | $15.27 | $229.05M |
| 2026-03-02 | Petras Michael B. Jr. | Chairman & CEO | Option exercise | 89.7K | — | — |
| 2026-03-02 | Petras Michael B. Jr. | Chairman & CEO | Grant | 240.2K | $0.00 | $0 |
| 2026-03-02 | DIMITRIEF ALEXANDER | SVP, General Counsel and Sec. | Option exercise | 16.8K | — | — |
| 2026-03-02 | Rutz Michael P | President of Sterigenics | Option exercise | 14.6K | — | — |
| 2026-03-02 | Rutz Michael P | President of Sterigenics | Grant | 45.2K | $0.00 | $0 |
| 2026-03-02 | Lyons Jonathan M. | Sr. Vice President, CFO | Option exercise | 17.9K | — | — |
| 2026-03-02 | Lyons Jonathan M. | Sr. Vice President, CFO | Grant | 59.4K | $0.00 | $0 |
1–10 of 10